QUININE COMPOUNDS, AND OPTICAL ISOMERS, PREPARATION METHOD AND MEDICAL USE THEREOF
申请人:Beijing Fswelcome Technology Development Co., Ltd
公开号:EP3023424A1
公开(公告)日:2016-05-25
The present invention discloses a class of quinine compounds and pharmaceutically acceptable salts, solvates, prodrugs or optical isomers thereof. Also disclosed in the present invention are that the above compounds have a selective antagonistic effect on the receptor subtypes of M1 and M3, but have no significant effect on M2 receptor subtype, and the above compounds are characterized by rapid action, long-lasting efficacy, and low toxic and side-effects when used to treat rhinitis, post-cold rhinitis, chronic trachitis, airway hyperresponsiveness, asthma, chronic obstructive pulmonary diseases, cough, urinary incontinence, frequent urination, unstable bladder syndrome, bladder spasms, bladder inflammation and gastrointestinal diseases such as irritable bowel syndrome, spastic colitis, as well as duodenal and gastric ulcers.
本发明公开了一类奎宁化合物及其药学上可接受的盐、溶液剂、原药或光学异构体。本发明还公开了上述化合物对M1和M3受体亚型具有选择性拮抗作用,但对M2受体亚型无明显作用,上述化合物用于治疗鼻炎具有作用迅速、疗效持久、毒副作用小的特点、上述化合物在治疗鼻炎、感冒后鼻炎、慢性沙眼、气道高反应性、哮喘、慢性阻塞性肺病、咳嗽、尿失禁、尿频、膀胱不稳定综合征、膀胱痉挛、膀胱炎和肠易激综合征、痉挛性结肠炎等胃肠道疾病以及十二指肠溃疡和胃溃疡时,具有作用迅速、疗效持久、毒副作用小的特点。